Literature DB >> 33682801

Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection in an Italian cohort in Marche Region, Italy.

Mauro De Santi1, Aurora Diotallevi2, Giorgio Brandi3.   

Abstract

BACKGROUND AND AIM: The COVID-19 is an infectious disease caused by the novel coronavirus SARS-CoV-2, declared a public health emergency by the World Health Organization. In this study, we evaluated the seroconversion of SARS-CoV-2 antibodies to find predictors of infection in terms of symptoms, health status, and professions.
METHODS: Serological samples of 341 volunteers in a cohort in Marche Region, Italy, were analyzed for the presence of IgM and/or IgG immunoglobulins specific for the SARS-CoV-2. Contextually, an anamnestic questionnaire was administered. The binary logistic regression analysis was used to find the predictors of seroconversion.
RESULTS: Forty-nine subjects (14.4 %) were found positive, without significant differences between gender and age groups. The predictors identified inside the variable categories "symptoms," "risk factors" (smoking habit and established pathologies), and "professions" were the loss of taste and smell (OR, 8.563), cardiovascular diseases (OR, 2.912), and policeman profession (OR, 3.875), respectively.
CONCLUSIONS: Although the limited number of subjects recruited in this study, our results could give important findings to be considered for planning preventive strategies in the view of the next COVID-19 waves.

Entities:  

Year:  2021        PMID: 33682801     DOI: 10.23750/abm.v92i1.10847

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


  6 in total

1.  Seroprevalence of SARS-CoV-2 in a Large Cohort of Italian Police Officers.

Authors:  Sergio Garbarino; Alexander Domnich; Elisabetta Costa; Irene Giberti; Stefano Mosca; Cristiano Belfiore; Fabrizio Ciprani; Giancarlo Icardi
Journal:  Int J Environ Res Public Health       Date:  2021-11-20       Impact factor: 3.390

2.  Epidemiology of SARS-CoV-2 Infection in Italy Using Real-World Data: Methodology and Cohort Description of the Second Phase of Web-Based EPICOVID19 Study.

Authors:  Fulvio Adorni; Nithiya Jesuthasan; Elena Perdixi; Aleksandra Sojic; Andrea Giacomelli; Marianna Noale; Caterina Trevisan; Michela Franchini; Stefania Pieroni; Liliana Cori; Claudio Maria Mastroianni; Fabrizio Bianchi; Raffaele Antonelli-Incalzi; Stefania Maggi; Massimo Galli; Federica Prinelli
Journal:  Int J Environ Res Public Health       Date:  2022-01-24       Impact factor: 3.390

3.  Prevalence of SARS-CoV-2 infection in the workplace: results of a year of investigation in the Marche Nord companies.

Authors:  Chiara Orlandi; Chiara Orlandi; Giuditta Fiorella Schiavano; Giorgio Brandi; Mauro Magnani; Anna Casabianca
Journal:  Acta Biomed       Date:  2021-10-01

4.  Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination.

Authors:  Simone Barocci; Chiara Orlandi; Aurora Diotallevi; Gloria Buffi; Marcello Ceccarelli; Daniela Vandini; Eugenio Carlotti; Luca Galluzzi; Marco Bruno Luigi Rocchi; Mauro Magnani; Anna Casabianca
Journal:  Vaccines (Basel)       Date:  2022-03-23

5.  SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy.

Authors:  Serena Marchi; Gianvito Lanave; Michele Camero; Francesca Dapporto; Alessandro Manenti; Linda Benincasa; Angela Acciavatti; Giulio Brogi; Simonetta Viviani; Emanuele Montomoli; Claudia Maria Trombetta
Journal:  Viruses       Date:  2022-06-30       Impact factor: 5.818

6.  Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Rome, Italy during the COVID-19 Outbreak.

Authors:  Francesca Lombardi; Rosalba Ricci; Simone Belmonti; Massimiliano Fabbiani; Alberto Borghetti; Gianmaria Baldin; Arturo Ciccullo; Enrica Tamburrini; Elena Visconti; Maurizio Sanguinetti; Simona Di Giambenedetto
Journal:  Diagnostics (Basel)       Date:  2021-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.